- Country: Ukraine
- Summary: Azithromycin, Lyophilisate/Powder for Solution, 500 Mg Each; Bupivacaine, Solution for Spinal Anesthesia, 5 Mg/Ml, 5 Ml Each; Vancomycin Lyophilisate/Powder for Solution for Infusion 500 Mg Each; Enoxaparin Sodium...
- UAT Ref No: 133794208
- Deadline: 17 Jan 2026
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: UAH 2897806
- Notice Type: Tender
- Document Ref. No.: UA-2026-01-14-002881-a
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Azithromycin, lyophilisate/powder for solution, 500 mg each; Bupivacaine, solution for spinal anesthesia, 5 mg/ml, 5 ml each; Vancomycin lyophilisate/powder for solution for infusion 500 mg each; Enoxaparin sodium, solution for injection, 10,000 anti-Xa IU/ml, 0.2 ml each; Enoxaparin sodium, solution for injection, 10,000 anti-Xa IU/ml, 0.4 ml each; Enoxaparin sodium, solution for injection, 10,000 anti-Xa IU/ml, 0.8 ml each; Electrolytes and combinations solution for infusions, 500 ml each; Calcium gluconate solution for injection 100 mg/ml in 10 ml; Magnesium sulfate, solution for injection, 250 mg/ml, 5 ml each; Mannitol solution for infusions 150 mg/ml 200 ml; Metamizole sodium, solution for injection, 500 mg/ml, 2 ml; Metronidazole, solution for infusions, 5 mg/ml per 100 ml; Sodium bicarbonate solution for infusions 40 mg/ml 200 ml; Sodium chloride, solution for injection, 9 mg/ml, 5 ml each; Sodium chloride, solution for infusions, 9 mg/ml 1000 ml; Sodium chloride, solution for infusions, 9 mg/ml 200 ml; Sodium chloride, solution for infusions, 9 mg/ml 400 ml; Omeprazole 40 mg bottle; Paracetamol solution for infusion 10 mg/ml 100 ml; Piperacillin/tazobactam, powder (lyophilisate) for solution, 4 g/0.5 g each; Theophylline solution for injection 20 mg/ml in 5 ml; Fluconazole, solution for infusions, 2 mg/ml, 100 ml each; Cefepime, powder for injection 1.0; Cefotaxime, powder for injections of 1 g each; Ciprofloxacin solution for infusions, 2 mg/ml per 100 ml; Ceftazidime, powder for injection 1.0 g Purchase type: goods Classifier and its corresponding code: DK 021:2015: 33600000-6 — Pharmaceutical products Bupivacaine, solution for spinal anesthesia, 5 mg/ml, 5 ml each; Electrolytes and combinations: Classification according to INN: Electrolytes, Classification according to ATX: B05BB01, Release form: Solution for infusions, Packaging type: Bottle, Volume: 500 milliliters, Magnesium chloride hexahydrate: 0.2 mg/ml, Potassium chloride: 0.3 mg/ml, Calcium chlor...
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINAzithromycin, Lyophilisate/Powder for Solution, 500 Mg Each; Bupivacaine, Solution for Spinal Anesthesia, 5 Mg/Ml, 5 Ml Each; Vancomycin Lyophilisate/Powder for Solution for Infusion 500 Mg Each; Enoxaparin Sodium... - Ukraine Tender
The PUBLIC NON-COMMERCIAL ENTERPRISE "CLINICAL HOSPITAL #15 OF THE PODIL DISTRICT OF THE CITY OF KYIV" OF THE EXECUTIVE BODY OF THE KYIV CITY COUNCIL (KYIV CITY STATE ADMINISTRATION), a Government sector organization in Ukraine, has announced a new tender for Azithromycin, Lyophilisate/Powder for Solution, 500 Mg Each; Bupivacaine, Solution for Spinal Anesthesia, 5 Mg/Ml, 5 Ml Each; Vancomycin Lyophilisate/Powder for Solution for Infusion 500 Mg Each; Enoxaparin Sodium.... This tender is published on UkraineTenders under UAT Ref No: 133794208 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2026-01-17.
The estimated tender value is UAH 2897806, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
